In this webinar, learn the benefits of utilizing demand-led supply and direct-to-patient distribution models in the clinical supply chain, as well as how they can be used to both improve flexibility and better align with patient needs. Register now.
Learn why consolidating Discovery, Pre-Clinical, Clinical, and Post Approval processes on a single platform drives efficiencies, margin improvement, and real time collaboration internally & externally. Register now!
Join us for a live webcast that will showcase valuable case studies and new methodologies that can help the wider CDMO industry in tackling delays in project deliveries. We will also cover our strategy to ensure the delivery of drugs to customers and patients in spite of the COVID-19 outbreak. Register now.
US biopharma companies have options for ex-US expansion. But how can a company decide on its best pathway to value? In this webinar, leaders who’ve done it outline how they weighed their options and made the right decisions.
In this webinar, Catalent Biologics shares how to transition your product from pre-filled syringe to auto-injector more quickly with an experienced partner who can anticipate equipment and process needs. Register now.
Join this webinar to learn how to more efficiently engage with customers remotely using your digital footprint, how to maximize product launches virtually, and how to proactively identify customer support needs by leveraging analytics and insights. Register now!
COVID-19 has presented the industry with many risks and challenges to the management of clinical trials. For many, the mitigation of these issues has accelerated the implementation of decentralized approaches to trials. Join us as we discuss these issues, ways they can be addressed, and Rho as a case study. Register now.
In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. The experts share collaborative best practices and explain how features of Catalent’s OneXpress™ can reduce risks, accelerate timelines, and maximize utilization of resources across a global network to drive more successful outcomes. Watch now.
This webinar will place the oncology patient and the drug company at the heart of the conversation and will give situational awareness of the challenges both parties face, along with the proven solutions to help overcome these challenges. Register now.
Leverage spray drying to combat bioavailability and processing challenges. Learn more as global industry experts provide insight from early development to commercialization. Register now.
In this webinar, learn how an advanced quality management system (QMS) that connects data across the product life cycle can provide business intelligence insights and give management a better understanding of your processes and how to improve them. Register now.
Whether you’re developing a COVID-19 treatment or introducing a new drug to the market, serialization is a requirement. Learn why a configurable solution will get you to compliance faster, future-proof your deployments and reduce total cost of ownership. Register now.
Cancer experts and pharma execs will break down the headline-making data from ESMO, sharing their insights and analysis around the conference’s most closely watched studies. This discussion will examine how groundbreaking research unveiled over the weekend will change clinical practice and prime drugs for key new indications, and panelists will fill you in on the need-to-know takeaways from oncology’s hottest fields. Register now.
Learn how technology transfers can optimize success and mitigate risk from product development to commercial launch. Register now!
This webinar will explain the baseline requirements for elastomeric physicochemical and functional properties. Examples to illustrate qualification of components for intended applications will be included. Register now.
The widespread adoption of smartphones and wearables makes monitoring symptoms in real time a credible option using brief measures designed for these devices – but is this acceptable and feasible for patients? This webinar will delve into the research findings of Takeda Pharmaceuticals, Cambridge Cognition, and CTRL Group, and share lessons learned adopting new technologies in clinical trials. Register now.
This webinar will focus on the challenges isolated populations have faced during the global pandemic related to patient adherence, and the application of formulation strategies to create more patient centric solutions. Register now.
Join experts Prof. Gerhard Bauer and Catalent’s Dr. James Crutchley as they discuss challenges and an innovative methodology to commercially scale autologous therapies. Register now.
Do you want to better engage with your customers in the new normal? Do you want to know about the secret sauce to perfecting omni-channel marketing? Join the experts to review the current strategies and discuss the key enablers to driving a personalized customer experience. Register now.
This webinar will detail practical implementation of innovative technologies and solutions such as multi-attribute method, modernized cell line development workflow using high-yield cell lines and automated systems, next generation purification resins. It will also showcase best practices and strategies such as phase appropriate quality systems, and integrated drug substance – drug product solutions that leverage standardized technology platforms. Register now!
The original goal of cell and gene therapy was to deliver a single administration that would maintain therapeutic effectiveness over a patient’s lifetime. This ‘one and done’ model appears to have worked for some gene therapies, where promising follow-up data has been observed. In some instances, however, such as in the case of gene therapy for hemophilia, a single dose may not be enough and redosing may be required. In this webinar, our speakers will discuss: strategies for both one-time and redosing gene therapies, what redosing means for the commercialization strategy, considerations for manufacturing and market access. Register now.
Optum brings together cross-industry experts to share a case study detailing how an employer, provider, payer and pharmaceutical company worked together to address a hard-to-diagnose condition: migraine. Register now.
Hybrid, Virtual, and Synthetic trials are becoming part of a growing number of drug and biologics development programs. Join us as Rho experts discuss how to maximize the benefits of decentralized trials. Register now!
Before businesses can recover, they will need to reboot, which will involve developing a holistic approach to managing new health risks, rethinking workforce safety, maximizing productivity, and furthering sales –while protecting and maintaining compliance with privacy and cybersecurity rights. Register now.
Join us to discuss strategy, timing, process, practical and execution aspects to be considered in order to achieve a target outcome. Case studies will be presented that demonstrate each of these challenges and the considerations necessary to meet fast-track timing requirements of clinical trials and registration applications. Register now.
In this webinar you will hear from technology company uMotif on how they collaborate with pharma companies undertaking virtual and decentralized trials. Hear how new patient populations can be reached using cloud-based technology and learn what types of research data can be collected from different devices and wearables. Register now.
Join us to gain an understanding of how to combine two different polymers, one “inside” and one “outside” the ASD to maximize performance, physical stability, and drug loading of ASD drug products. Register now.
Continuous manufacturing brings uncertainties with regulatory and adoption rates. Industry expert, Ajaz S. Hussain, PhD, will discuss these uncertainties and provide more insight into this innovation. Register now!
Regulatory agencies have provided recommendations on when and how to identify and characterize drug metabolites to ensure their non-clinical toxicity has been adequately evaluated. The studies conducted to comply with these recommendations are often referred to as metabolites in safety testing or MIST.
This presentation will review the origins of these recommendations and the specific requirements that need to be considered in designing studies to address the regulatory expectations. Register now.
This virtual roundtable will explore the challenges and opportunities facing companies developing oncology and rare disease products during the COVID-19 pandemic. Parexel will be joined by Sara’s Cure, a Clear Cell Sarcoma patient advocacy group and charitable foundation. Register now to learn more.
It’s not uncommon for companies who launch commercial drug products in the pre-filled syringe format to do so after initially using other product formats such as vials for the development and clinical trial phases. Switch-overs need careful and strategic consideration because doing so requires investment in the new format but also offers critical patient benefits and improved stakeholder outcomes. During this webinar, you will learn more about benefits and risks of changing primary components during product development and how a design of experiments approach can be used to address issues and risks. Register now.
Cell & gene therapy supply chains are inherently complex, requiring the utmost attention to quality, cold chain logistics, and chain of custody requirements. Join Thermo Fisher Scientific and Pluristem Therapeutics as we discuss lessons learned in developing the just-in-time supply chain for their phase III hip fracture study, and how these lessons are being used in their current efforts to treat severe COVID-19 cases complicated by Acute Respiratory Distress Syndrome (ARDS) in the United States. Register Now.
This presentation will benefit scientists wanting to learn more about DILI and/or those needing guidance on crucial transporter studies for better assessment of DDI potentials that is aligned with regulatory guidance. Register for our Webinar, featuring Kan He, on BSEPcyte® and MDR3cyte®: Innovative Solutions for Investigating Drug-Induced Liver Injury.
By establishing an early dialogue with the FDA—when potential products are still in preclinical testing—companies can gain valuable insights that could boost their chances of success. This webinar will bring together experts in preclinical trial design, R&D efficiency and regulatory affairs to offer advice on how companies can best engage the FDA early in the research process. Register now.
Join this webinar to hear Joel VanderMeulen, Senior Director, N&I Commercial Strategy and Operations at EMD Serono, and Derek Choy, Co-founder and President at Aktana, discuss:
- Emerging market trends in the post-COVID world
- How commercial teams can adapt to the “next normal”
- The three key components for successful omnichannel engagement
There is a high attrition rate during the development of biotherapeutics impacting the high cost of development. Early identification of the preferred expression host for manufacturing, along with lead candidate screening and material supply can help to reduce both attrition rates and cost. Register for the webinar to learn more.
In this webinar, Optum will bring together their life sciences consultants, a large payer and pharmaceutical industry experts to share understanding about how patients are managing their medications — and how payers are managing patients — in the ever-changing COVID-19 world. Register now.
We are in unprecedented times causing change and disruption like deferral of elective procedures and restricted access to HCPs. In this webinar, you will learn how MedTech companies are planning to rebound from COVID-19 by digitally re-engaging with physicians, HCPs, and health systems as elective procedure volume rebounds. Register now.
In this webinar we will examine a number of the benefits of Lonza’s , XS® Pichia 2.0 including : speed, simple fermentation regimes, robust and scalable processes that can be tuned according to the specific objectives of a program, helping to advance new drug candidates through the development pipeline. We will examine the benefits of XS® Pichia 2.0 by referencing a number of case studies with different molecule formats. Register now.
This webinar will present the results from BHE's industry survey with FiercePharma on how 100 of your peers are leveraging data analytics to respond to today’s challenges and generate timely, high value insights. The webinar will discuss how data analytics are being conducted across functional areas, how analytics approaches vary according to company size and type, which real-world data sources are most commonly leveraged, and more. Register now!
FierceBiotech’s upcoming series will cover technology’s role in clinical trials. Panel discussions include: the use of sensors, wearables and other remote monitoring devices for tracking patient statistics, real-world data and patient-centric technology, and the role manufacturing plays in clinical trials. Register now.
This Fierce webinar will bring together executives with expertise in biopharma discovery, R&D and clinical trial design to discuss the benefits and challenges of the fail-fast strategy. It will include representatives of companies that have implemented such a strategy successfully and can provide advice on what did and did not work. Click here to register!
Register for our Webinar, featuring David Kwok, on Human Gut Microbiome-Based Contract Research Applications in Toxicology and Microbiome-Based Drug Discovery. Save your spot & register today!
Rapid and systematic column and mobile phase screening has become an essential component of method development workflows at Cambrex Durham for NCE APIs and drug products. Utilizing the latest technologies in UPLC, a systematic approach to screening in method development can quickly provide more robust methods earlier in the clinical development lifecycle. Register now.
Join this webcast as experts present the exclusive survey findings and introduce innovative scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability. Register now.
During the current COVID-19 pandemic, regulatory and compliance risk is an acute concern by health authorities, pharmaceutical manufacturers, medical practitioners and patients. This webinar will discuss the challenges and potential mitigation strategies, in accordance with appropriate application of regulations and COVID-19 guidance documents, to ensure GCP compliance with respect to managing lost to follow-up and missing data. Register now.
Join us for a webcast that will announce our progress on the 2020 investments to our Pharma Services business and provide focused insight on Thermo Fisher Scientific's expanding gene therapy capabilities. We will also cover an update on our strategy to ensure the delivery of drugs to customers and patients in lieu of the COVID-19 outbreak, as well as our evolving direct response to the virus through several ongoing projects. Register Now.
This webinar will explore real-world examples that will help you anticipate pitfalls, mitigate risk and accelerate development. Use the valuable insights we’ve gained from participation in multiple COVID-19 research studies to understand the contingencies for success and, just as critical, to anticipate pitfalls that can be avoided. Click here to save your spot!
RxMx’s Chameleon -- built on InterSystems IRIS for Health® -- features a configurable platform and a suite of apps to support the unique needs and challenges facing specialty medicines. Join this webinar to learn how the team has developed a variety of products to support solutions ranging from managing COVID-19 test data to keeping MS patients on track for scheduled infusions.
Join industry experts as they propose best practices for incorporating translational omic data in clinical development in order to yield novel insights and improve patient / study outcomes. Register now.